Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia

Ahmed Aribi, Hagop M. Kantarjian, Elihu H. Estey, Charles A. Koller, Deborah A. Thomas, Steven M. Kornblau, Stefan H. Faderl, Nakia M. Laddie, Guillermo Garcia-Manero, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences